Pharmacogenetic (CYP2D6) and gene expression profiles (HOXB13/IL17BR and molecular grade index) for prediction of adjuvant endocrine therapy benefit in the ABCSG 8 trial.
- M Goetz (Author)
- M Ames (Author)
- M Gnant (Author)
- M Filpits (Author)
- R Jakesz (Author)
- R Greil (Author)
- C Marth (Author)
- Hellmut Samonigg (Author)
- V Suman (Author)
- S Safgren (Author)
- M Kuffel (Author)
- R Weinshilboum (Author)
- M Erlander (Author)
- XJ Ma (Author)
- J Ingle (Author)
Activity: Talk, presentation or poster › Scientific talk or presentation › On site